Product logins

Find logins to all Clarivate products below.


Blog: Biopharma

Here you will find relevant articles and insight into all Clarivate related products and news.

The competitive signals hiding in plain sight for biopharma The competitive signals hiding in plain sight for biopharma
Blog May 8, 2026
The competitive signals hiding in plain sight for biopharma
Biopharma Business Development Clinical trials
Five lessons learned deploying agentic AI in the life sciences Five lessons learned deploying agentic AI in the life sciences
Blog April 30, 2026
Five lessons learned deploying agentic AI in the life sciences
AI
Target selection and safety assessment: Navigating early decisions that shape drug development Target selection and safety assessment: Navigating early decisions that shape drug development
Blog March 27, 2026
Target selection and safety assessment: Navigating early decisions that shape drug development
Development Pharma Regulatory
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
Blog March 26, 2026
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
GLP-1 Metabolic
Why longevity might be biopharma's next big thing: The science and business converge Why longevity might be biopharma's next big thing: The science and business converge
Blog March 2, 2026
Why longevity might be biopharma's next big thing: The science and business converge
Gerontology
Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
Biopharma Biotech Clinical trials
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Biopharma Biotech Clinical trials
Relacorilant:  when evidence meets the established evidence bar Relacorilant:  when evidence meets the established evidence bar
Blog February 24, 2026
Relacorilant: when evidence meets the established evidence bar
FDA Regulatory Safety

Biopharma

Resilient supply chain requires geographic diversity Resilient supply chain requires geographic diversity
Blog September 1, 2020
Resilient supply chain requires geographic diversity
Aducanumab: On the verge of making history in Alzheimer’s disease Aducanumab: On the verge of making history in Alzheimer’s disease
Blog August 21, 2020
Aducanumab: On the verge of making history in Alzheimer’s disease
Drug discovery pipeline Drug discovery pipeline
Blog August 20, 2020
The future of continuous manufacturing in pharma
Blog August 13, 2020
Trump targets drug prices – 5 implications for pharma
Patient enrollment continues to be a limiting factor for trial durations Patient enrollment continues to be a limiting factor for trial durations
Blog August 10, 2020
Patient enrollment continues to be a limiting factor for trial durations
Understanding disruptions to the antibiotic supply resulting from COVID-19 Understanding disruptions to the antibiotic supply resulting from COVID-19
Blog August 6, 2020
Understanding disruptions to the antibiotic supply resulting from COVID-19
Retail Giants Reshaping Primary-Care Focus Retail Giants Reshaping Primary-Care Focus
Blog August 4, 2020
Retail Giants Reshaping Primary-Care Focus
Gaining insight with artificial intelligence Gaining insight with artificial intelligence
Blog July 13, 2020
Gaining insight with artificial intelligence
Organ-specific toxicity and personalized approaches Organ-specific toxicity and personalized approaches
Blog July 13, 2020
Organ-specific toxicity and personalized approaches
Identifying risks in drug discovery Identifying risks in drug discovery
Blog July 13, 2020
Identifying risks in drug discovery